- Home
- AAOI vs MNKD Comparison
AAOI vs MNKD Comparison
Compare AAOI & MNKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AAOI
- MNKD
- Stock Information
- Founded
- AAOI 1997
- MNKD 1991
- Country
- AAOI United States
- MNKD United States
- Employees
- AAOI N/A
- MNKD N/A
- Industry
- AAOI Semiconductors
- MNKD Biotechnology: Pharmaceutical Preparations
- Sector
- AAOI Technology
- MNKD Health Care
- Exchange
- AAOI Nasdaq
- MNKD Nasdaq
- Market Cap
- AAOI 1.6B
- MNKD 1.7B
- IPO Year
- AAOI 2013
- MNKD 2004
- Fundamental
- Price
- AAOI $24.17
- MNKD $5.27
- Analyst Decision
- AAOI Buy
- MNKD Buy
- Analyst Count
- AAOI 6
- MNKD 6
- Target Price
- AAOI $28.40
- MNKD $10.25
- AVG Volume (30 Days)
- AAOI 5.6M
- MNKD 4.4M
- Earning Date
- AAOI 11-06-2025
- MNKD 11-05-2025
- Dividend Yield
- AAOI N/A
- MNKD N/A
- EPS Growth
- AAOI N/A
- MNKD 23.47
- EPS
- AAOI N/A
- MNKD 0.10
- Revenue
- AAOI $421,712,000.00
- MNKD $313,787,000.00
- Revenue This Year
- AAOI $96.63
- MNKD $14.78
- Revenue Next Year
- AAOI $62.31
- MNKD $19.36
- P/E Ratio
- AAOI N/A
- MNKD $53.63
- Revenue Growth
- AAOI 101.25
- MNKD 17.43
- 52 Week Low
- AAOI $9.71
- MNKD $3.38
- 52 Week High
- AAOI $44.50
- MNKD $7.44
- Technical
- Relative Strength Index (RSI)
- AAOI 36.53
- MNKD 44.43
- Support Level
- AAOI $28.20
- MNKD $4.95
- Resistance Level
- AAOI $32.20
- MNKD $6.24
- Average True Range (ATR)
- AAOI 3.02
- MNKD 0.29
- MACD
- AAOI -1.39
- MNKD -0.04
- Stochastic Oscillator
- AAOI 3.44
- MNKD 21.71
About AAOI Applied Optoelectronics Inc.
Applied Optoelectronics Inc is a provider of fiber-optic networking products, for four networking end-markets; internet data center, CATV, telecom, and FTTH. The Company designs and manufactures a wide range of optical communications products at varying levels of integration, from components, subassemblies, and modules to complete turn-key equipment. Through direct sales personnel, and manufacturing teams in the United States, China, and Taiwan, the company coordinates with customers to determine product design, qualifications, and performance. The Company has manufacturing and research and development facilities located in the U.S., Taiwan, and China.
About MNKD MannKind Corporation
MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.